within Pharmacolibrary.Drugs.N_NervousSystem.N07A_Parasympathomimetics.N07AA02_Pyridostigmine;

model Pyridostigmine
  extends Pharmacolibrary.Drugs.ATC.N.N07AA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N07AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pyridostigmine is an orally active cholinesterase inhibitor primarily used for the symptomatic treatment of myasthenia gravis. It increases the concentration of acetylcholine at neuromuscular junctions, enhancing neuromuscular transmission. It is approved and remains in clinical use today.</p><h4>Pharmacokinetics</h4><p>Reported in healthy adult volunteers after single oral dose.</p><h4>References</h4><ol><li><p>Aquilonius, SM, et al., &amp; Osterman, PO (1980). Pharmacokinetics and oral bioavailability of pyridostigmine in man. <i>European journal of clinical pharmacology</i> 18(5) 423–428. DOI:<a href=\"https://doi.org/10.1007/BF00636797\">10.1007/BF00636797</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7439266/\">https://pubmed.ncbi.nlm.nih.gov/7439266</a></p></li><li><p>Cohan, SL, et al., &amp; O&#x27;Doherty, DS (1976). The pharmacokinetics of pyridostigmine. <i>Neurology</i> 26(6 PT 1) 536–539. DOI:<a href=\"https://doi.org/10.1212/wnl.26.6.536\">10.1212/wnl.26.6.536</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/945494/\">https://pubmed.ncbi.nlm.nih.gov/945494</a></p></li><li><p>Taylor, T, et al., &amp; Chung, H (1991). Pharmacokinetics of pyridostigmine in dogs. <i>Journal of pharmaceutical sciences</i> 80(4) 353–356. DOI:<a href=\"https://doi.org/10.1002/jps.2600800414\">10.1002/jps.2600800414</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1865335/\">https://pubmed.ncbi.nlm.nih.gov/1865335</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Pyridostigmine;
